10Wu CC, Ho YZ, Ho WL, et al. Preoperative transcatheter arterial chemoembolization for resectable large hepatocellular carcinoma: a reappraisal [J].Br J Surg, 1995,82 ( 1 ) : 122- 126.
5Departments of Surgical Oncology (Wu FS, Zhao WH, Ma ZM, Teng LS and Wang M) and General Surgery ( Liang TB and Zheng SS) , First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.Survival factors after resection of small hepatocellular carcinoma[J].Hepatobiliary & Pancreatic Diseases International,2005,4(3):379-384. 被引量：5
4Lee MJ,Mueller PR,Dawson SL,et al.Percutaneous ethanol injection for the treatment of hepatic tumors:indications,mechanism of action,technique,and efficacy[J].AJR Am J Roentgenol,1995;164(1):215-220.
6Bartolozzi C,Lencioni R,Caramella D,et al.Treatment of large HCC:transcatheter arterial chemoembolization combined with percutaneous ethanol injection versus repeated transcatheter arterial chemoembolization[J].Radiology,1995;197(3):812-818.
7Ishii H,Okada S,Sato T,et al.Effect of percutaneous ethanol injection for postoperative recurrence of hepatocellular carcinoma in combination with transcatheter arterial embolization[J].Hepatogastroenterology,1996;43(9):644-650.
8Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002[J]. CA Cancer J Clin, 2005, 55 (2) : 742-108.
9Zheng LB, Guo YH, Yu HY, et al. Correlation between levels of serum growth differentiation factor - 15 and acute coronary syn- drome [J]. Seijing Da Xue Xue Bao, 2011,43(2): 250-254.
10Bruix J, Sherman M ; American Association for the Study of Liv- er Diseases. Management of hepatocellular carcinoma : an up- date[ J]. Hepatology, 2011,53 ( 3 ) : 1020-1022.
